GLAUKOS Corp APIC, Share-based Payment Arrangement, Increase for Cost Recognition
GLAUKOS Corp (GKOS) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $28.86 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-07-29
- GLAUKOS Corp apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $28.86M, a 60.19% increase year-over-year.
- GLAUKOS Corp apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $19.14M, a 47.42% increase year-over-year.
- GLAUKOS Corp apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-09-30 was $14.91M, a 3.42% increase year-over-year.
- GLAUKOS Corp apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $18.02M, a 59.28% increase year-over-year.
- GLAUKOS Corp apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $63.22M, a 25.91% increase from fiscal 2024.
- GLAUKOS Corp apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $50.21M, a 15.34% increase from fiscal 2023.
- GLAUKOS Corp apic, share-based payment arrangement, increase for cost recognition for fiscal 2023 was $43.53M, a 12.88% increase from fiscal 2022.
- GLAUKOS Corp apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $38.56M, a 27.91% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $28.86M 10-Q · filed 2026-07-29 | $48.01M derived: sum of 2 quarters · filed 2026-07-29 | ||
| 2026-03-31 | $19.14M 10-Q · filed 2026-07-29 | |||
| 2025-12-31 | $63.22M 10-K · filed 2026-02-23 | |||
| 2025-09-30 | $14.91M 10-Q · filed 2025-10-31 | $32.93M derived: sum of 2 quarters · filed 2026-07-29 | $45.92M derived: sum of 3 quarters · filed 2026-07-29 | |
| 2025-06-30 | $18.02M 10-Q · filed 2026-07-29 | $31.00M derived: sum of 2 quarters · filed 2026-07-29 | ||
| 2025-03-31 | $12.99M 10-Q · filed 2026-07-29 | |||
| 2024-12-31 | $50.21M 10-K · filed 2026-02-23 | |||
| 2024-09-30 | $14.42M 10-Q · filed 2025-10-31 | $25.73M derived: sum of 2 quarters · filed 2025-10-31 | $36.90M derived: sum of 3 quarters · filed 2025-10-31 | |
| 2024-06-30 | $11.31M 10-Q · filed 2025-10-31 | $22.48M derived: sum of 2 quarters · filed 2025-10-31 | ||
| 2024-03-31 | $11.16M 10-Q · filed 2025-10-31 | |||
| 2023-12-31 | $43.53M 10-K · filed 2026-02-23 | |||
| 2023-09-30 | $10.48M 10-Q · filed 2024-11-05 | $20.36M derived: sum of 2 quarters · filed 2024-11-05 | $30.54M derived: sum of 3 quarters · filed 2024-11-05 | |
| 2023-06-30 | $9.87M 10-Q · filed 2024-11-05 | $20.06M derived: sum of 2 quarters · filed 2024-11-05 | ||
| 2023-03-31 | $10.18M 10-Q · filed 2024-11-05 | |||
| 2022-12-31 | $38.56M 10-K · filed 2025-02-25 | |||
| 2022-09-30 | $9.41M 10-Q · filed 2023-11-01 | $19.95M derived: sum of 2 quarters · filed 2023-11-01 | $26.87M derived: sum of 3 quarters · filed 2023-11-01 | |
| 2022-06-30 | $10.54M 10-Q · filed 2023-11-01 | $17.46M derived: sum of 2 quarters · filed 2023-11-01 | ||
| 2022-03-31 | $6.92M 10-Q · filed 2023-11-01 | |||
| 2021-12-31 | $30.15M 10-K · filed 2024-02-23 | |||
| 2021-09-30 | $6.19M 10-Q · filed 2022-11-04 | $14.17M derived: sum of 2 quarters · filed 2022-11-04 | $22.92M derived: sum of 3 quarters · filed 2022-11-04 | |
| 2021-06-30 | $7.98M 10-Q · filed 2022-11-04 | $16.73M derived: sum of 2 quarters · filed 2022-11-04 | ||
| 2021-03-31 | $8.75M 10-Q · filed 2022-11-04 | |||
| 2020-12-31 | $48.64M 10-K · filed 2023-02-24 | |||
| 2020-09-30 | $9.66M 10-Q · filed 2021-11-08 | $22.72M derived: sum of 2 quarters · filed 2021-11-08 | $39.90M derived: sum of 3 quarters · filed 2021-11-08 | |
| 2020-06-30 | $13.06M 10-Q · filed 2021-11-08 | $30.24M derived: sum of 2 quarters · filed 2021-11-08 | ||
| 2020-03-31 | $17.18M 10-Q · filed 2021-11-08 | |||
| 2019-12-31 | $36.39M 10-K · filed 2022-02-28 | |||
| 2019-09-30 | $8.55M 10-Q · filed 2020-11-05 | $16.79M derived: sum of 2 quarters · filed 2020-11-05 | $23.92M derived: sum of 3 quarters · filed 2020-11-05 | |
| 2019-06-30 | $8.25M 10-Q · filed 2020-11-05 | $15.38M derived: sum of 2 quarters · filed 2020-11-05 | ||
| 2019-03-31 | $7.13M 10-Q · filed 2020-11-05 | |||
| 2018-12-31 | $25.70M 10-K · filed 2021-03-01 | |||
| 2018-09-30 | $7.17M 10-Q · filed 2019-11-06 | $13.63M derived: sum of 2 quarters · filed 2019-11-06 | $19.04M derived: sum of 3 quarters · filed 2019-11-06 | |
| 2018-06-30 | $6.46M 10-Q · filed 2019-11-06 | $11.86M derived: sum of 2 quarters · filed 2019-11-06 | ||
| 2018-03-31 | $5.40M 10-Q · filed 2019-11-06 | |||
| 2017-12-31 | $17.59M 10-K · filed 2020-03-02 | |||
| 2016-12-31 | $8.79M 10-K · filed 2019-02-28 | |||
| 2015-12-31 | $7.89M 10-K · filed 2018-02-28 | |||
| 2014-12-31 | $1.53M 10-K · filed 2017-03-15 | |||
| 2013-12-31 | $1.35M 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |